CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus (Q45371233)

13 December 2017

CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus (English)

1 reference

13 December 2017

10

Hans-Peter Hartung

1 reference

13 December 2017

12

Bernd C Kieseier

1 reference

13 December 2017

8

Heinz Wiendl

1 reference

13 December 2017

7

Gabriele Arendt

1 reference

13 December 2017

Clemens Warnke

1

1 reference

13 December 2017

Vsevolod Smolianov

2

1 reference

13 December 2017

Thomas Dehmel

3

1 reference

13 December 2017

Marcel Andrée

4

1 reference

13 December 2017

Hartmut Hengel

5

1 reference

13 December 2017

Fabian Zohren

6

1 reference

13 December 2017

Rainer Haas

9

1 reference

13 December 2017

Ortwin Adams

11

1 reference

13 December 2017

15 November 2010

1 reference

Multiple Sclerosis Journal

13 December 2017

1 reference

13 December 2017

17

1 reference

13 December 2017

2

1 reference

13 December 2017

151-156

1 reference

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation

13 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Progressive multifocal leukoencephalopathy in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Asymptomatic reactivation of JC virus in patients treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Reemergence of PML in natalizumab-treated patients--new cases, same concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Does infection influence plaque stability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

α4Integrins as Therapeutic Targets in Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385834

21 January 2018

Identifiers

DOI

10.1177/1352458510385834

1 reference

13 December 2017

1 reference